TI
VYGR icon

Trexquant Investment’s Voyager Therapeutics VYGR Stock Holding History

Trexquant Investment’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,904
Closed -$84.5K – 1836
2023
Q3 		$84.5K Sell
10,904
-33,348
-75% -$305K ﹤0.01% 1398
2023
Q2 		$507K Buy
+44,252
New +$458K 0.01% 995
2020
Q3 		– Sell
-30,703
Closed -$387K – 1560
2020
Q2 		$387K Sell
30,703
-36,473
-54% -$424K 0.03% 772
2020
Q1 		$615K Buy
67,176
+45,818
+215% +$526K 0.04% 588
2019
Q4 		$298K Buy
21,358
+6,937
+48% +$101K 0.02% 752
2019
Q3 		$248K Buy
+14,421
New +$303K 0.02% 678
2019
Q1 		– Sell
-21,504
Closed -$202K – 1348
2018
Q4 		$202K Buy
+21,504
New +$276K 0.01% 913
2018
Q2 		– Sell
-17,437
Closed -$328K – 1255
2018
Q1 		$328K Buy
17,437
+6,687
+62% +$145K 0.02% 782
2017
Q4 		$178K Buy
+10,750
New +$184K 0.02% 961

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Trexquant Investment's VYGR Position: Q4 2023 in Review

Trexquant Investment sold out of Voyager Therapeutics (VYGR) in Q4 2023, closing a stake of 10,904 shares — an estimated $84.5K sold.

Trexquant Investment first reported a position in VYGR in Q4 2017 and held it in 9 quarters. The position peaked at $615K in Q1 2020. 107 funds tracked by Wall St. Rank hold VYGR as of Q4 2023.

  • Trexquant Investment reported no remaining Voyager Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Trexquant Investment sold 10,904 Voyager Therapeutics shares in Q4 2023, an estimated $84.5K.
  • Trexquant Investment first reported a position in Voyager Therapeutics in Q4 2017 and held it in 9 quarters.
  • Trexquant Investment's Voyager Therapeutics position peaked at $615K in Q1 2020.
  • 107 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2023.

Based on Trexquant Investment's 13F filing for Q4 2023, filed 9 Feb 2024.